Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017;55(3):1019-1029.
doi: 10.3233/JAD-160614.

Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity

Affiliations

Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity

Kamini Krishnan et al. J Alzheimers Dis. 2017.

Abstract

Background: The logopenic variant of primary progressive aphasia (lvPPA) manifests due to a breakdown of the language network with prominent hypometabolism of the left temporoparietal region. LvPPA is strongly associated with amyloid deposition, yet there is question as to whether it is a homogeneous clinical entity.

Objective: This study investigated whether differences in temporoparietal metabolic patterns on 18F fludeoxyglucose positron emission tomography (FDG-PET) could elucidate brain regions preferentially affected in lvPPA.

Method: We used differences in FDG-PET metabolic z-scores relative to controls for means of left lateral temporal, left inferior parietal, and left superior parietal regions to classify 53 amyloid-positive lvPPA patients into temporal, parietal, or temporoparietal predominate groups. Clinical features and FDG-PET regions of hypometabolism outside of the temporoparietal region were then compared across the three groups; the latter using statistical parametric mapping.

Results: Of the 53 lvPPA patients, 15 were classified as temporal, 14 as temporoparietal, and 22 as parietal predominate. There were no significant differences between the groups on demographic measures, language evaluation, or apolipoprotein E genotype. Compared to the other two groups, individuals with the parietal predominate pattern had extensive hypometabolism in left frontal lobe and the precuneus. Furthermore, this group had greater behavioral dyscontrol and deficits in executive function, visuospatial skills, visual memory retention, working memory, and cognitive flexibility (Bonferronip < 0.05).

Conclusions: This study demonstrates that there is clinical heterogeneity within amyloid-positive lvPPA. Patients with lvPPA with predominant parietal hypometabolism, unlike those with temporal or temporoparietal predominant hypometabolism, demonstrated widespread cognitive and behavioral changes.

Keywords: 18F fludeoxyglucose; Amyloid-β; executive function; positron emission tomography; primary progressiveaphasia; visuospatial deficit; working memory.

PubMed Disclaimer

Conflict of interest statement

Disclosures of conflict of interest

The other authors report no disclosures.

Figures

Figure 1
Figure 1. Patterns of FDG-PET hypometabolism in the three lvPPA groups compared to controls
Glass brain renders showing patterns of FDG-PET hypometabolism in the parietal, temporoparietal, and temporal predominate lvPPA groups compared to controls. Results are shown after correction for multiple comparisons at p<0.001. Red arrows highlight the voxel with the peak t score for each comparison.
Figure 2
Figure 2. Patterns of FDG-PET hypometabolism in the three lvPPA groups compared to each other
Glass brain renders showing a direct comparisons of the three lvPPA groups, uncorrected for multiple comparisons at p<0.001. Red arrows highlight the voxel with the peak t score for each comparison.
Figure 3
Figure 3. Amyloid-β deposition on PiB-PET in both lvPPA groups
Glass brain renders showing amyloid-β deposition on PiB-PET in the parietal, temporoparietal, and temporal predominate lvPPA groups, corrected for multiple comparisons at p<0.001.

Similar articles

Cited by

References

    1. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–1014. - PMC - PubMed
    1. Botha H, Duffy JR, Whitwell JL, Strand EA, Machulda MM, Schwarz CG, Reid RI, Spychalla AJ, Senjem ML, Jones DT, Lowe V, Jack CR, Josephs KA. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech. Cortex; a journal devoted to the study of the nervous system and behavior. 2015;69:220–236. - PMC - PubMed
    1. Teichmann M, Kas A, Boutet C, Ferrieux S, Nogues M, Samri D, Rogan C, Dormont D, Dubois B, Migliaccio R. Deciphering logopenic primary progressive aphasia: a clinical, imaging and biomarker investigation. Brain : a journal of neurology. 2013;136:3474–3488. - PubMed
    1. Mesulam MM, Weintraub S, Rogalski EJ, Wieneke C, Geula C, Bigio EH. Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia. Brain : a journal of neurology. 2014;137:1176–1192. - PMC - PubMed
    1. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ, Jack CR, Jr, Whitwell JL. APOE epsilon4 influences beta-amyloid deposition in primary progressive aphasia and speech apraxia. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2014;10:630–636. - PMC - PubMed

Publication types

LinkOut - more resources